Literature DB >> 6548219

Synthesis and antitumor activity of 3'-deamino-3'-hydroxydoxorubicin. A facile procedure for the preparation of doxorubicin analogs.

D Horton, W Priebe, O Varela.   

Abstract

Two successful routes have been developed for preparation of 3'-deamino-3'-hydroxydoxorubicin (11), based on protection of the 14-hydroxyl group of the aglycon by using tert-butylchlorodimethylsilane. The key intermediate, 14-O-tert-butyldimethylsilyl-7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-ly xo -hexopyranosyl)adriamycinone (9), was successively deacetylated and desilylated in high yield to give the desired product 11. This route constitutes a general method of access to glycon-modified doxorubicin analogs. Compound 11 showed high antitumor activity in vivo in the murine P388 lymphocytic leukemia assay.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548219     DOI: 10.7164/antibiotics.37.853

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin.

Authors:  R Perez-Soler; W Priebe
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Synthesis and in vitro efficacy of MMP9-activated NanoDendrons.

Authors:  Lynn E Samuelson; Randy L Scherer; Lynn M Matrisian; J Oliver McIntyre; Darryl J Bornhop
Journal:  Mol Pharm       Date:  2013-06-24       Impact factor: 4.939

3.  Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents.

Authors:  Dennis P A Wander; Sabina Y van der Zanden; Gijsbert A van der Marel; Herman S Overkleeft; Jacques Neefjes; Jeroen D C Codée
Journal:  J Med Chem       Date:  2020-10-16       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.